Global In Vitro Diagnostics Market - Forecasts from 2018 to 2023
Global in vitro diagnostics market is valued at US$67.055 billion in 2017 and is projected to expand at a CAGR of 5.45% over the forecast period to reach US$92.172 billion by 2023. In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body to detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases. The robust growth in the market may be attributed to the rising incidences of the chronic and infectious diseases across the globe. Increasing investment by the companies for new product development is also the major reason for growth of the market.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the in vitro diagnostics value chain. The last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global radio modem market.
Major industry players profiled as part of the report are Roche Diagnostics, Omega Diagnostics Group PLC, DST Diagnostische Systeme & Technologien GmbH and SD Biosensor among others.
Segmentation
In the report, global in vitro diagnostics market has been segmented by Product Type, by End-user industries, and by geography
By Technique
Immunoassay
Molecular diagnostics
Haematology
Other
By Application
Infectious diseases
Autoimmune diseases
Drug testing
Oncology
Others
By End-user
Diagnostic Laboratories
Hospitals and clinics
Research Labs and institutes
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa (MEA)
Asia Pacific (APAC)
China
Japan
India
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the in vitro diagnostics value chain. The last step involves complete market engineering which includes analysing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the global radio modem market.
Major industry players profiled as part of the report are Roche Diagnostics, Omega Diagnostics Group PLC, DST Diagnostische Systeme & Technologien GmbH and SD Biosensor among others.
Segmentation
In the report, global in vitro diagnostics market has been segmented by Product Type, by End-user industries, and by geography
By Technique
Immunoassay
Molecular diagnostics
Haematology
Other
By Application
Infectious diseases
Autoimmune diseases
Drug testing
Oncology
Others
By End-user
Diagnostic Laboratories
Hospitals and clinics
Research Labs and institutes
By Geography
North America
United States
Canada
Others
South America
Brazil
Argentina
Others
Europe
United Kingdom
Germany
France
Others
Middle East and Africa (MEA)
Asia Pacific (APAC)
China
Japan
India
Others
1. INTRODUCTION
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Pipeline Products
5. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY TECHNIQUE (US$ BILLION)
5.1. Immunoassay
5.2. Molecular Diagnostics
5.3. Haematology
5.4. Others
6. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY APPLICATION
6.1. Infectious diseases
6.2. Autoimmune diseases
6.3. Drug Testing
6.4. Oncology
6.5. Others
7. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY END-USER
7.1. Diagnostic Laboratories
7.2. Hospitals and Clinicals
7.3. Research Laboratories and Institutes
8. GLOBAL SELF SERVICE TICKET MACHINES MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. US
8.1.2. Canada
8.1.3. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. France
8.3.4. Others
8.4. Asia Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Others
8.5. Middle East and Africa
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Roche Diagnostics
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Key Developments
10.2. Plasmatec
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Key Developments
10.3. Master Diagnóstica
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Key Developments
10.4. Omega Diagnostics Group PLC & Technologien GmbH
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Key Developments
10.5. DST Diagnostische Systeme
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Key Developments
10.6. SD Biosensor
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Key Developments
10.7. Abbott Diagnostics
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Key Developments
10.8. Meril Diagnostics
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Key Developments
10.9. NIPPON GENE CO., LTD.
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Key Developments
10.10. Rapid Diagnostics Group of Companies
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Key Developments
List of Tables
List of Figures
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. KEY FINDINGS OF THE STUDY
4. MARKET DYNAMICS
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Pipeline Products
5. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY TECHNIQUE (US$ BILLION)
5.1. Immunoassay
5.2. Molecular Diagnostics
5.3. Haematology
5.4. Others
6. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY APPLICATION
6.1. Infectious diseases
6.2. Autoimmune diseases
6.3. Drug Testing
6.4. Oncology
6.5. Others
7. GLOBAL IN VITRO DIAGNOSTICS MARKET FORECAST BY END-USER
7.1. Diagnostic Laboratories
7.2. Hospitals and Clinicals
7.3. Research Laboratories and Institutes
8. GLOBAL SELF SERVICE TICKET MACHINES MARKET FORECAST BY GEOGRAPHY
8.1. North America
8.1.1. US
8.1.2. Canada
8.1.3. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. France
8.3.4. Others
8.4. Asia Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Others
8.5. Middle East and Africa
9. COMPETITIVE INTELLIGENCE
9.1. Market Share Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. COMPANY PROFILES
10.1. Roche Diagnostics
10.1.1. Overview
10.1.2. Financials
10.1.3. Product and Services
10.1.4. Key Developments
10.2. Plasmatec
10.2.1. Overview
10.2.2. Financials
10.2.3. Product and Services
10.2.4. Key Developments
10.3. Master Diagnóstica
10.3.1. Overview
10.3.2. Financials
10.3.3. Product and Services
10.3.4. Key Developments
10.4. Omega Diagnostics Group PLC & Technologien GmbH
10.4.1. Overview
10.4.2. Financials
10.4.3. Product and Services
10.4.4. Key Developments
10.5. DST Diagnostische Systeme
10.5.1. Overview
10.5.2. Financials
10.5.3. Product and Services
10.5.4. Key Developments
10.6. SD Biosensor
10.6.1. Overview
10.6.2. Financials
10.6.3. Product and Services
10.6.4. Key Developments
10.7. Abbott Diagnostics
10.7.1. Overview
10.7.2. Financials
10.7.3. Product and Services
10.7.4. Key Developments
10.8. Meril Diagnostics
10.8.1. Overview
10.8.2. Financials
10.8.3. Product and Services
10.8.4. Key Developments
10.9. NIPPON GENE CO., LTD.
10.9.1. Overview
10.9.2. Financials
10.9.3. Product and Services
10.9.4. Key Developments
10.10. Rapid Diagnostics Group of Companies
10.10.1. Overview
10.10.2. Financials
10.10.3. Product and Services
10.10.4. Key Developments
List of Tables
List of Figures
